Acquisition expands Bora’s North American footprint with first US manufacturing site Taipei, Taiwan, April 1st, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that it has successfully completed the ... Read More
Maple Grove, MN – March 29, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately ... Read More
Maple Grove, MN – February 6, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) proudly announce the recipients of the 2023 NASPA Excellence in Innovation Award. This annual ... Read More
Osaka, Japan – January 17, 2024 – Sawai Group Holdings Co., Ltd. (Sawai Group, Head office: Osaka, Japan, President: Mitsuo Sawai) announced that its Board of Directors, at a meeting held on January 16, resolved ... Read More
Taipei, Taiwan, January 16th, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer ... Read More
For many Americans, getting a generic medicine involves a simple trip to a local pharmacy or a quick check of their mailbox. But for people who really know the industry, the picture is more complicated—and, ... Read More
